We're building a better ClinicalTrials.gov. Check it out and tell us what you think!

Key Record Dates

ClinicalTrials.gov Identifier: NCT03470805
Brief Title: Olaparib After Response to Trabectedin-pegylated Liposomal Doxorubicin in Recurrent Ovarian Carcinoma

First Submitted : February 28, 2018
First Submitted that Met QC Criteria : March 19, 2018
First Posted : March 20, 2018

Last Update Submitted that Met QC Criteria : September 22, 2022
Last Update Posted : September 23, 2022